Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 12:32 AM UTC
| NCT Number | NCT06588686 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 270 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Vicore Pharma AB |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of June 2, 2026: Clinical trial NCT06588686 is currently active_not_recruiting participants. This clinical trial study for idiopathic pulmonary fibrosis is not currently accepting new participants at 26 locations across the United States. The study is sponsored by Vicore Pharma AB. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06588686 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06588686 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.